Title
Category
Credits
Event date
Cost
IO Therapies in the Advanced Bladder Cancer Clinic: Aligning Your Team for Success
  • Oncology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • Participation
$0.00
As the treatment paradigm for bladder cancer continuously evolves, all members of the oncology healthcare team must be equipped to evolve with it to ensure optimal patient care. With this evolution comes many questions for the bladder cancer treatment team. Join Drs. Neal Shore, Arjun Balar, Lidia Lopez, and Nurse Joanie Pfahl as they examine the new paradigm of bladder treatment using ICIs, and discuss the important role of each person on the treatment team.
Navigating the Patient Journey in Chronic Lymphocytic Leukemia: Oncology Nurse Strategies in Therapy Management
  • Oncology
  • ANCC
  • Participation
$0.00
Nurse and physician expert faculty will discuss the emerging advances in the treatment of chronic lymphocytic leukemia (CLL) with novel agents targeting the B-cell receptor (BCR) pathway, and the latest, top-line safety and efficacy trial data for monotherapy and combination therapy strategies for CLL in first- and later-line settings. Attendees will understand how to differentiate between the different novel agents available with regard to efficacy, adverse event profile, and other relevant clinical factors.
Medical Moment Three: Multidisciplinary Collaboration  in the Management of Patients with Heart Failure
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Heart failure is a major public-health problem resulting in substantial morbidity and mortality for the US. Unfortunately, challenges and barriers to effective use of guideline-directed medical therapies (GDMT) among hospitalized patients with HFrEF remain. Join Drs. Muthiah Vaduganathan and Amulya Nagarur as they discuss practical strategies and insights into using GDMT, and opportunities for multidisciplinary partnerships when treating these patients.Supported through an independent educational grant from Merck.
Medical Moment One: Novel Pharmacologic Approaches in a Symptomatic, High-risk HFrEF Patient Population
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Join Drs. Muthiah Vaduganathan and Javed Butler for this on-demand online activity, as they examine novel methodologies to address the clinical worsening of HFrEF, with a focus on recently-reported results from the VICTORIA trial.Supported through an independent educational grant from Merck.
Medical Moment Two: Multifaceted Challenges in Medical Therapy Optimization during Episodes of Worsening HFrEF
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Initiating and optimizing in-hospital guideline-directed medical therapies (GDMT) remains a challenge for clinicians treating patients with worsening HFrEF. Join Drs. Muthiah Vaduganathan and Michelle Kittleson, as they discuss opportunities and strategies to employ evidence-based therapies to address these challenges.Supported through an independent educational grant from Merck.
New Horizons in Ovarian Cancer: Expert Insights into the Role of Genetic Biomarkers in Precision Therapy
  • Oncology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Click here for activity.
Navigating the Patient Journey in Chronic Lymphocytic Leukemia: Oncology Nurse Strategies in Therapy Management
  • Oncology
  • ANCC
  • Participation
$0.00
Click here for activity.
Applying ADAURA in Practice: Implications for Early Stage EGFRm NSCLC - Medical Moment Two
  • Oncology
  • Pulmonology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Medical Moment Two: Expert Insight on Applying the ADAURA Results to Treatment of Early-Stage NSCLC Patients 
Applying ADAURA in Practice: Implications for Early Stage EGFRm NSCLC - Medical Moment One
  • Oncology
  • Pulmonology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Medical Moment One: Expert Insight on Practical Aspects of Molecular Profiling for Early-Stage NSCLC Cancers 
Overcoming Disparity with Novelty in Triple-Negative Breast Cancer: Community Oncology Perspectives on Promoting Equity and Improving Clinical Outcomes
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
12/21/2021
$0.00

Pages